Lightnews — Scholar-powered news

Reposted by Cancer Therapy Advisor

Oncology Nurse Advisor @oncologynurseadv.bsky.social · 1h

In this new column,
@breastcancerorg.bsky.social explores the unsaid messages patients with #breastcancer get from their oncology nurses.

https://bit.ly/4715UtH

#bcsm #BCAM #BreastCancerAwarenessMonth

Beyond Side Effects: Seeing the Whole Person in Breast Cancer Care - Oncology Nurse Advisor

In this new column, Breastcancer.org explores the unsaid messages patients with breast cancer get from their oncology nurses.

bit.ly

1 1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 2h

New guidelines provide recommendations on the use of postmastectomy radiation therapy in patients with #breastcancer. From @ascopost.bsky.social and @annsurgoncology.bsky.social.

https://bit.ly/4nQpz5e

#bcsm #BreastCancerAwarenessMonth #BCAM

1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 2d

Carboplatin plus etoposide, with or without focal treatments, may be safe and effective for patients with high-risk intraocular #retinoblastoma.

https://bit.ly/435PgGy

#pedcsm

Combo Appears Safe, Effective in High-Risk Intraocular Retinoblastoma

The ocular event-free survival rate was 43.2% at 1 year, 31.1% at 2 years, and 29.5% at 5 years.

bit.ly

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 2d

ChatGPT does not generally provide accurate information when responding to patient questions about #hematologiccancers.

https://bit.ly/4gZMpVt

#leusm #lymsm #mmsm

ChatGPT Falls Short When Answering Questions About Hematologic Cancers

“Responses regarding novel therapies and genetic mutations were often found to lack relevant details or were not up to date, reflecting either insufficient knowledge, outdated resources, or limited access to current advancements in these areas,” the res...

bit.ly

2

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 3d

The rate of death from second primary malignancies has increased among older #prostatecancer survivors in the United States.

https://bit.ly/4ocCoqB

#pcsm #gucsm

Deaths From Second Primary Malignancies Are Rising in Prostate Cancer Survivors

To quantify second primary malignancy-related deaths, researchers analyzed data from the US Centers for Disease Control and Prevention's WONDER database.

bit.ly

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 5d

Adding ribociclib to adjuvant NSAI therapy improves iDFS over NSAI therapy alone in HR-positive/ERBB2-negative early #breastcancer, even 1 year after stopping treatment. Published in @jamaoncology.com.

https://bit.ly/4h3eGuA

#bcsm #BreastCancerAwaressMonth

Adjuvant Ribociclib Offers Ongoing DFS Benefit in HR+/HER2- Early Breast Cancer

In HR+/HER- early breast cancer, the DFS benefits of adjuvant ribociclib plus NSAI treatment compared to NSAI alone persisted even a year after treatment completion.

bit.ly

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 6d

In #cancer patients who undergo surgery, legalization of medical #marijuana with accompanying state-run dispensaries appears to lead to fewer prescriptions for strong opioids. Published in @americancancersoc.bsky.social.

https://bit.ly/4nF6qTI

Medical Marijuana Legalization Impacts Opioid Use, Hospital Visits in Cancer Surgery Patients

Compared to no legalization, medical marijuana legalization with state-run dispensaries appears to increase the risk of adverse hospital events among cancer patients receiving surgery.

bit.ly

1 1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 7d

TTFields treatment following stereotactic radiosurgery prolonged the time to intracranial progression for patients with brain metastases from NSCLC, according to research presented at #ASTRO25 by Dr Vinai Gondi.

shorturl.at/cIx6O

#lcsm #NSCLC #ASTRO2025

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 7d

In men with prostate cancer, prophylactic whole pelvic radiotherapy does not improve OS compared to prostate-only dose-escalated radiotherapy. Presented at #ASTRO25 by Dr Mack Roach of @ucsfradonc.bsky.social.

shorturl.at/GWacU

#pcsm #gucsm #ASTRO2025

1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 8d

The @fda.gov has accepted for review the sBLA for fam-THP for the neoadjuvant treatment of adult patients with HER2-positive (immunohistochemistry [IHC] 3+ or ISH+) stage 2 or 3 #breastcancer. From @medicalprofref.bsky.social.
https://bit.ly/4nDx1AR

#bcsm #BreastCancerAwarenessMonth

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 8d

Recent moves by the govt could create or exacerbate cancer drug shortages, experts say. With @jrgralow.bsky.social of @ascocancer.bsky.social, Dr Kenneth Komorny of @moffittnews.bsky.social, @mfleury.bsky.social of @acscan.bsky.social, & Ted Okon of COA.

Read or listen here: shorturl.at/jzp1q

Drug Shortages Remain a Threat to Cancer Care, Experts Say

Continued drug shortages remain a possibility, and recent moves by the government could create or exacerbate cancer drug shortages.

www.cancertherapyadvisor.com

1 3

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 8d

Recurrent prostate cancer patients with luminal B tumors may benefit from hormone therapy added to radiation following surgery, according to research presented at #ASTRO25.

shorturl.at/BF1EP

#pcsm #gucsm #ASTRO2025

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 9d

A 4-part strategy to collect data on SOGI from #cancer patients appears feasible.

https://bit.ly/46XwRNE

Strategy Aids Collection of SOGI Data From Cancer Patients

“A MyChart-driven data collection strategy proved acceptable, appropriate, and feasible for gathering SOGI information from patients at a cancer center in the South,” the researchers wrote.

bit.ly

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 9d

Clonal hematopoiesis of indeterminate potential is the strongest predictor of whether daily low-dose #aspirin could help prevent #cancer in healthy, older adults. Published in @jamaoncology.com.

https://bit.ly/46FugYc

Daily Low-Dose Aspirin May Decrease Cancer Risk for Some Adults, Study Suggests

“Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers reported.

bit.ly

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 11d

Dr Ashwin Kishtagari (@ashkishtaagri.bsky.social) of @vumedicine.bsky.social shares his top picks from #SOHO2025. #SOHO25 Read about them here:
www.cancertherapyadvisor.com/features/soh...

Dr Ashwin Kishtagari’s Top 4 Picks From SOHO 2025

Ashwin Kishtagari, MD, shares his top 4 picks from the abstracts presented at the 13th annual meeting of the Society of Hematologic Oncology.

www.cancertherapyadvisor.com

1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 11d

Adjuvant radiotherapy improves locoregional failure-free survival, compared with observation, in patients with locally advanced MIBC, according to research presented at #ASTRO25. #blcsm #gucsm #astro2025
shorturl.at/kWlRH

1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 13d

#Cancerdeaths have increased by more than 70% globally over the last 3 decades and are estimated to continue to climb, with more than 18 million cancer deaths projected in 2050. These findings were published in @thelancetoncol.bsky.social.

https://bit.ly/42Htid9

#lcsm #gicsm #bcsm

Researchers Estimate More Than 18 Million Cancer Deaths Worldwide in 2050

Overall, 41.7% of cancer deaths in 2023 were attributed to potentially modifiable risk factors, with behavioral risk factors having the greatest impact.

bit.ly

2

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 14d

Men with #prostatecancer who closely follow the @americancancersoc.bsky.social cancer survivor guidelines after diagnosis have lower all-cause and cardiovascular mortality compared to those who do not. Published in @jamanetworkopen.com.

https://bit.ly/4nYWww9

#pcsm #gucsm

Following ACS Survivor Guidelines Reduces Mortality in Men with Prostate Cancer

Men who improve their adherence to ACS guidelines following diagnosis have a reduction in all-cause and cardiovascular mortality compared to those who maintain a low concordance with guideline recommendations.

bit.ly

1 1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 15d

Findings from the phase 2 ISASOCUT study support the use of subcutaneous isatuximab plus VRd as a new standard of care in newly diagnosed MM, said Dr Arthur Bobin of @chu-poitiers.bsky.social, who presented these results at #IMS25. #IMS2025 #mmsm shorturl.at/iSblj

1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 15d

The AACR Cancer Progress Report 2025 highlights recent advances in cancer research, emphasizing the importance of federal funding. @theaacr.bsky.social Read or listen to our coverage here: shorturl.at/YDWsz

Report Highlights Progress Made Possible by Federal Funding for Cancer Research

The AACR Cancer Progress Report 2025 highlights recent advances in cancer research, emphasizing the importance of federal funding.

shorturl.at

1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 15d

The efficacy of systemic therapy varies among patients with rare #skincancers, but patients with cutaneous adnexal carcinoma have poor outcomes regardless of the therapy they receive.

https://bit.ly/42yPlT2

#skcsm

Systemic Therapy More Effective for Some Rare Skin Cancers Than Others

“Type and outcome of systemic therapy differed between cancer entities,” the researchers wrote.

bit.ly

1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · 16d

Consolidative radiotherapy at the time of the expected best response to osimertinib was considered well tolerated and demonstrated “promising efficacy” in patients with advanced, EGFR-mutant #NSCLC. From the @eclinicalmed.bsky.social.

https://bit.ly/46f62Fq

“Less Complex” Regimen Shows Promise for Advanced, EGFR-Mutant NSCLC

Consolidative radiotherapy at the time of the expected best response to osimertinib demonstrated “promising efficacy” in EGFR-mutant NSCLC, researchers reported.

bit.ly

1